Leinco Technologies has developed proprietary methods for manufacturing In vivo functional grade antibodies with the highest purity standards in the industry. Leinco’s In vivo PLATINUM™ antibodies have the most stringent quality specifications for purity, endotoxins, aggregates and leachable protein A. Each antibody is available in custom concentrations and package sizes. In vivo PLATINUM™ antibodies are also pathogen free and tested by the IDEXX Impact I PCR mouse pathogen profile.
Custom size options, quality and value are why we continue to use Leinco over all others in the life science research industry.
– Lab Manager at Washington University in St. Louis
Name
| Applications ? | Prod No.
| Clone
| Pkg. Size / Quantity |
|---|---|---|---|---|
Alt Names: CD159a, CD159c, CD159e, NKG2C, NKG2E Reactivity: Mouse Immunogen: CHO transfected cells expressing the C57BL/6 allele of NKG2A and CD94 |
B , FC , IHC |
N561 |
20D5 |
|
Alt Names: CD159a, CD159c, CD159e, NKG2C, NKG2E Reactivity: Mouse Immunogen: CHO transfected cells expressing the C57BL/6 allele of NKG2A and CD94 |
B , FC , IHC |
N560 |
20D5 |
|
FA , FC |
I-444 |
|||
Alt Names: DEFA5; DEF5; HD-5 Reactivity: Human Immunogen: Recombinant Human HD5 (aa 20-94). |
Dot , ELISA , IHC FFPE , WB |
D400 |
8C8 |
|
Alt Names: DEFA5; DEF5; HD-5 Reactivity: Human Immunogen: Recombinant Human HD5 (aa 20-94). |
Dot , ELISA , IHC FFPE , WB |
D405 |
8C8 |
|
Alt Names: IFNGR1, IFNg Ra Reactivity: Human Immunogen: Human IFN-γRα, Purified from human placenta |
FA , FC |
I-443 |
GIR-208 |
|
Alt Names: IFNGR1, IFN-γR, IFN-γRα, IFN-α R1, CDw119 Reactivity: Human Immunogen: Human IFN-γRα, Purified from human placenta |
FA , FC |
G737 |
GIR-208 |
|
Alt Names: LFA-1α chain, ITGAL Reactivity: Human Immunogen: Unknown |
Costim , FC , WB |
C373 |
38 |
|
Alt Names: LFA-1α chain, ITGAL Reactivity: Human Immunogen: Unknown |
Costim , FC , WB |
C673 |
38 |
|
Alt Names: Mac-1, Integrin αM chain, C3biR, CR3, Mo1, ITGAM Reactivity: Human Immunogen: unknown |
CODEX® , FC , IF Staining , IHC FF |
C368 |
ICRF44 |